Nasorinit (Azelastine Hydrochloride, Fluticasone Propionate)

Azelastine Hydrochloride and Fluticasone Propionate, the active ingredients in Nasorinit, are an antihistamine and a corticosteroid presented as a nasal spray for intranasal use. They are indicated for the relief of allergic rhinitis symptoms in adults and children, reducing nasal congestion, sneezing, and itching.

GNH USA supplies Nasorinit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets, including batch release certificates and stability data.

Nasorinit, containing azelastine and fluticasone, is used to manage allergic rhinitis and related nasal inflammation.

Allergic rhinitis (seasonal): reduces nasal congestion, sneezing, and itching. Perennial allergic rhinitis: controls chronic nasal symptoms and improves airflow. Non‑allergic rhinitis with inflammatory component: may improve nasal patency and reduce discharge.

The most frequently reported reactions with Nasorinit are related to local nasal irritation and mild systemic effects.

Common Side Effects: - Nasal irritation or burning sensation - Bitter or unpleasant taste - Headache - Epistaxis (nosebleed) - Cough or throat clearing - Transient nasal dryness

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or ocular pressure increase - Adrenal suppression with prolonged high‑dose use - Secondary infection of the nasal mucosa

Before prescribing Nasorinit, clinicians should consider several safety aspects.

Assess severity of nasal disease: ensure appropriate indication before use. Recent nasal surgery or trauma: avoid use until mucosa has healed. Glaucoma or cataract patients: monitor intra‑ocular pressure. Pregnancy and lactation: use only if potential benefit outweighs risk. Children under recommended age: follow label age restrictions. Store at ambient temperature: keep below 25 °C, in original container, protected from moisture and direct sunlight.

Nasorinit may interact with other medications that influence corticosteroid or antihistamine activity.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise fluticasone levels. - Monoamine oxidase inhibitors: may potentiate antihistamine sedation.

Moderate Interactions (Monitor Closely): - Other intranasal decongestants: risk of rebound congestion. - Anticholinergic drugs: may exacerbate nasal dryness. - Herbal supplements containing St. John’s wort: possible induction of metabolism.